Express Scripts Holding Company (ESRX) Given Average Recommendation of “Hold” by Analysts

Express Scripts Holding Company (NASDAQ:ESRX) has earned an average rating of “Hold” from the twenty-six research firms that are currently covering the company, MarketBeat Ratings reports. Six research analysts have rated the stock with a sell recommendation, eleven have given a hold recommendation, seven have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $71.12.

ESRX has been the topic of a number of analyst reports. TheStreet upgraded shares of Express Scripts from a “c+” rating to a “b-” rating in a research report on Monday. Zacks Investment Research upgraded shares of Express Scripts from a “hold” rating to a “buy” rating and set a $64.00 price objective on the stock in a research report on Monday, October 16th. ValuEngine upgraded shares of Express Scripts from a “hold” rating to a “buy” rating in a research report on Monday, October 2nd. Jefferies Group set a $72.00 price objective on shares of Express Scripts and gave the company a “buy” rating in a research report on Tuesday, August 29th. Finally, Deutsche Bank initiated coverage on shares of Express Scripts in a research report on Monday. They set a “buy” rating and a $75.00 price objective on the stock.

In other Express Scripts news, CEO Timothy C. Wentworth acquired 8,000 shares of the stock in a transaction that occurred on Tuesday, October 31st. The stock was bought at an average cost of $61.13 per share, with a total value of $489,040.00. Following the completion of the purchase, the chief executive officer now directly owns 98,628 shares in the company, valued at $6,029,129.64. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Phyllis S. Anderson sold 643 shares of the company’s stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $62.37, for a total transaction of $40,103.91. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 5,121 shares of company stock worth $325,920. Company insiders own 0.68% of the company’s stock.

Large investors have recently added to or reduced their stakes in the stock. Burt Wealth Advisors lifted its stake in Express Scripts by 11.4% in the second quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock worth $108,000 after acquiring an additional 174 shares during the period. CKW Financial Group lifted its stake in Express Scripts by 20.0% in the second quarter. CKW Financial Group now owns 1,800 shares of the company’s stock worth $115,000 after acquiring an additional 300 shares during the period. Bank of Nova Scotia Trust Co. purchased a new stake in Express Scripts in the third quarter worth about $120,000. IHT Wealth Management LLC lifted its stake in Express Scripts by 8.1% in the first quarter. IHT Wealth Management LLC now owns 1,944 shares of the company’s stock worth $128,000 after acquiring an additional 145 shares during the period. Finally, FNY Partners Fund LP purchased a new stake in Express Scripts in the first quarter worth about $138,000. 88.44% of the stock is owned by institutional investors.

Shares of Express Scripts (ESRX) traded up $0.73 on Friday, reaching $68.57. 3,737,241 shares of the company traded hands, compared to its average volume of 4,119,528. Express Scripts has a 12 month low of $55.80 and a 12 month high of $76.38. The company has a market capitalization of $38,603.98, a PE ratio of 9.96, a PEG ratio of 1.01 and a beta of 0.88. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.73 and a quick ratio of 0.61.

Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings results on Tuesday, October 24th. The company reported $1.90 earnings per share for the quarter, hitting the consensus estimate of $1.90. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. The company had revenue of $24.68 billion for the quarter, compared to analysts’ expectations of $25.68 billion. During the same quarter in the previous year, the business posted $1.74 earnings per share. Express Scripts’s quarterly revenue was down 2.9% on a year-over-year basis. analysts anticipate that Express Scripts will post 7.01 earnings per share for the current year.

WARNING: “Express Scripts Holding Company (ESRX) Given Average Recommendation of “Hold” by Analysts” was first reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this news story on another site, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this news story can be viewed at https://www.com-unik.info/2017/12/06/express-scripts-holding-company-esrx-given-average-recommendation-of-hold-by-analysts.html.

Express Scripts Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Analyst Recommendations for Express Scripts (NASDAQ:ESRX)

What are top analysts saying about Express Scripts Holding Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Express Scripts Holding Company and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit